Skip to content
Dilanubicel
Dilanubicel is a cell pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
3 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470C92.022
Myelodysplastic syndromesD009190D4622
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.022
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_000034022
Non-hodgkin lymphomaD008228C85.911
Hiv infectionsD015658EFO_0000764B2011
Megakaryoblastic leukemia acuteD007947C94.211
AnemiaD000740EFO_0004272D64.911
Biphenotypic leukemia acuteD015456C95.011
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDILANUBICEL
INNdilanubicel
Description
Dilanubicel is a cell pharmaceutical. It is currently being investigated in clinical studies.
Classification
Cell
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4297239
ChEBI ID
PubChem CID
DrugBank
UNII IDFR89SC8CT4 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 0 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details